 therapi recombin granulocyt colony-stimul factor erythropoietin decreas toxic zidovudin twenty-two patient acquir immunodefici syndrom aid sever aids-rel complex multilineag hematopoiet defect recombin granulocyt colony-stimul factor g-csf erythropoietin epo phase i/ii trial patient neutropen anem withdraw bone marrow-suppress drug daili g-csf self-administ absolut neutrophil count anc week subcutan epo regimen dose increas g/l hemoglobin group patient dose zidovudin toler g-csf epo therapi dose modif anc g/l dose zidovudin patient g-csf mean increas neutrophil week signific increas cell number lymphocyt prolif respons bone marrow cellular epo therapi hemoglobin evalu patient week sixteen patient mg patient mg zidovudin day reinstitut zidovudin declin reticulocyt hemoglobin reappear transfus requir patient studi medic No patient studi medic neutropenia thrombocytopenia toxic mild dose modif dilut plasma lymphocyt co-cultur hiv serum antigen level g-csf g-csf epo therapi hiv antigen zidovudin therapi opportunist infect patient myelosuppress antimicrobi agent ganciclovir develop neutropenia result combin therapi g-csf epo neutropenia anemia aid therapi resumpt full-dos zidovudin patient intoler hematolog effect zidovudin appar alter hiv express efficaci zidovudin